Cargando…
Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia
Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364065/ https://www.ncbi.nlm.nih.gov/pubmed/32695366 http://dx.doi.org/10.1002/ccr3.2901 |
| _version_ | 1783559764059357184 |
|---|---|
| author | Lundholm, Michelle D. Charnogursky, Gerald A. |
| author_facet | Lundholm, Michelle D. Charnogursky, Gerald A. |
| author_sort | Lundholm, Michelle D. |
| collection | PubMed |
| description | Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly. |
| format | Online Article Text |
| id | pubmed-7364065 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-73640652020-07-20 Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia Lundholm, Michelle D. Charnogursky, Gerald A. Clin Case Rep Case Reports Tyrosine kinase inhibitors can cause significant hypoglycemia in patients with diabetes on other antihyperglycemic medications. These patients should be monitored, and their medications adjusted accordingly. John Wiley and Sons Inc. 2020-04-27 /pmc/articles/PMC7364065/ /pubmed/32695366 http://dx.doi.org/10.1002/ccr3.2901 Text en © 2020 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Case Reports Lundholm, Michelle D. Charnogursky, Gerald A. Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia |
| title | Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia |
| title_full | Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia |
| title_fullStr | Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia |
| title_full_unstemmed | Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia |
| title_short | Dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia |
| title_sort | dasatinib‐induced hypoglycemia in a patient with acute lymphoblastic leukemia |
| topic | Case Reports |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7364065/ https://www.ncbi.nlm.nih.gov/pubmed/32695366 http://dx.doi.org/10.1002/ccr3.2901 |
| work_keys_str_mv | AT lundholmmichelled dasatinibinducedhypoglycemiainapatientwithacutelymphoblasticleukemia AT charnogurskygeralda dasatinibinducedhypoglycemiainapatientwithacutelymphoblasticleukemia |